Case Study:
Finding New Insights Why Physicians Are Increasing or Decreasing their Prescribing of a Specific Brand Using AI
Finding New Insights Why Physicians Are Increasing or Decreasing their Prescribing of a Specific Brand Using AI
The Client
The client had conducted market research but it failed to explain some of the increases and decreases seen and they wanted to get a more granular real world data insight into some of the prescribing changes seen.
The Solution
They decided to turn to Artificial Intelligence to see if real world data could explain some of the things seen. We were able to access Prescribing data by physician on a monthly basis. On top of that we also had claims data which we could link to the physician, as well as physician profile data from AMA. This combination of data allowed us to find patterns in the data that shed some light on some of the prescribing changes. For example some physicians were constrained by their health plans which impacted this client brand, some geographic locations led to higher prescribing on brands (and we were able to then look at company internal data to understand some of the reasons behind this based on their activity),
The Outcome
A clearer understanding of some of the prescribing behaviour could be identified and the company then could develop plans to address them.
To achieve these kinds of results, contact Eularis today.
Latest News
Read our latest blogs here.
How to Spot and Prevent Deepfakes Spreading Medical Misinformation
Back in 2021, many people died and the US economy suffered losses worth $50-300 million each day – both from people refusing to get COVID-19
Multi-Agent Systems: The Limitless Potential of AI Agents in Healthcare and Pharma
Imagine a hospital where all the computer systems can talk to each other seamlessly, schedule appointments, and keep track of medical records without human intervention.
FDA Approved AI: Where Are We Today?
The U.S. Food and Drug Administration regulates certain AI/machine learning-based medical devices through its premarket review and approval pathways. Any software or device that utilizes